Knockdown of HSD17B13 mRNA, Pharmacokinetics, Safety, and Tolerability, of AZD7503 in Non-Alcoholic Fatty Liver Disease

Trial Identifier:	D9230C00003
Sponsor:	AstraZeneca
Start Date:	August 2022
Primary Completion Date:	November 2023
Study Completion Date:	February 2024

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English Version
	Spanish (United States) Translation

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
US, TX	San Antonio, TX, US, 78215

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.